Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe most common assumption about Wegovy and other medicines is that a weight-loss injection sits neatly apart from everything else in your medicine cabinet. It doesn't. Semaglutide slows gastric emptying, and that change in gut transit can shift how quickly your body absorbs other drugs — including some that need precise, predictable timing. Understanding what not to take with Wegovy, and why, is a practical safety question worth answering properly. These are prescription-only medicines assessed individually by a clinician, because the right answer depends on your full medicines list, not a blanket rule.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It's an understandable assumption. Injections bypass the gut, so they feel separate from the world of oral medicines. The problem is that semaglutide's effect on gastric emptying applies to everything you swallow afterwards. Food, fluids and oral medicines all spend longer in your stomach than they would otherwise, meaning absorption timing shifts. For most tablets that's a minor nuance with no clinical consequence. For a handful of drugs, it matters considerably.
The NHS medicines information for semaglutide is clear that patients should tell their prescriber and pharmacist about every medicine they take before starting Wegovy, and that includes over-the-counter medicines, herbal remedies and supplements. This isn't box-ticking. A delayed absorption peak can mean a drug either under-performs or hits harder at an unexpected time. Getting this right from the start is far simpler than troubleshooting it later. Our clinical team reviews each patient's medicines list as part of the consultation process, before any prescription is written.
There is also a separate category of true pharmacodynamic interactions, where semaglutide and another drug pull in the same or opposite direction physiologically, regardless of absorption timing. Diabetes medicines are the clearest example of this, and they deserve their own section.
Wegovy is licensed for weight management, but semaglutide also lowers blood glucose. If you are taking insulin or a sulfonylurea (medicines such as glibenclamide or gliclazide) alongside Wegovy, the combined glucose-lowering effect can push blood sugar lower than intended. Hypoglycaemia is the clinical concern, and it's one your prescriber will want to address directly.
This doesn't mean the combination is forbidden. It means doses of the diabetes medicine may need to be adjusted, and that adjustment is a clinical decision. Metformin, by contrast, carries a much lower hypoglycaemia risk on its own, and combining it with semaglutide is well documented in the trial literature. The British National Formulary entry for semaglutide lists the specific interactions flagged for prescribers, and your GP or specialist should be in the loop if your diabetes management changes while you're on Wegovy. Eating less is itself a mechanism that affects blood glucose, the interaction between appetite reduction and diabetes medicines begins on day one, before any chemistry.
If you're exploring what this means for your situation more broadly, the page on drugs that may conflict with Wegovy goes into further detail on specific prescription medicines.
Three categories of oral medicine come up repeatedly when patients ask this question, and each warrants a clear answer.
Oral contraceptives. The combined pill relies on consistent absorption. NHS guidance advises that women taking an oral contraceptive pill while on a GLP-1 medicine should use a barrier method as a backup for the first four weeks of treatment and for four weeks after any dose increase, because reduced gastric motility can affect how reliably the pill is absorbed. A non-oral method (an IUD, implant, or condoms) avoids the issue entirely. This is especially relevant when starting treatment or moving up through the dose schedule. The NHS England guidance on weight management injections addresses this directly.
HRT. Transdermal forms of HRT (patches and gels applied to the skin) bypass gut absorption altogether, so they're not affected by semaglutide's gastric-emptying effect. If you currently take oral HRT, it's worth discussing with your doctor whether a transdermal option would suit you during treatment.
Thyroid medication. Levothyroxine is one of the medicines most sensitive to timing and absorption conditions. It's already affected by coffee, calcium and various foods. Adding a gastric-emptying delay into the mix is a reason to flag this with your GP so they can monitor thyroid levels. The dose itself may not need to change, but keeping an eye on it is sensible.
Questions about the wider picture of what not to mix with semaglutide cover this territory in more depth, including supplements worth mentioning to your clinician.
Paracetamol, ibuprofen, antihistamines, most standard over-the-counter medicines are not affected meaningfully by semaglutide's gastric-emptying effect, though peak absorption timing may shift slightly. For occasional use, this rarely matters. For regular use of any OTC medicine, mentioning it to your prescriber is good practice, and if you want a thorough overview of what you cannot take with semaglutide, that page brings together the full list of medicines and substances worth discussing.
Alcohol deserves a practical note. Wegovy is commonly associated with reduced appetite and, for some people, reduced interest in alcohol too. But alcohol can worsen some of the gastrointestinal side effects of semaglutide (nausea in particular) and if you drink heavily, the combination can increase the risk of hypoglycaemia if you're also on glucose-lowering medicines. There's no blanket prohibition, but moderation makes the side-effect profile easier to manage.
Herbal supplements are a grey area because they're rarely studied alongside GLP-1 medicines. Some (like St John's Wort) have documented interactions with other prescription drugs; others are simply unknown quantities. The safe move is to list everything you take, including supplements, on your consultation form. It takes ten seconds and gives the prescriber the full picture.
If you want to understand what else to avoid or adjust while on treatment, the page on what not to do on Wegovy covers lifestyle factors alongside medicines. And if you're weighing up the cost and logistics of getting started privately, Wegovy pricing in the UK explains what a private prescription typically involves. When you're ready to take the next step, choosing which day of the week to take your Wegovy injection is one of the first practical decisions you'll make, and our guide walks you through it, then check your eligibility with our prescribers, the consultation is free, and your full medicines list is reviewed as part of it.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.